- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/566 - Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol having an oxo group in position 17, e.g. oestrone
Patent holdings for IPC class A61K 31/566
Total number of patents in this class: 285
10-year publication summary
19
|
35
|
30
|
24
|
22
|
37
|
33
|
35
|
29
|
4
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 18943 |
15 |
Regeneron Pharmaceuticals, Inc. | 3650 |
5 |
Sage Therapeutics, Inc. | 312 |
5 |
Skintech Life Science Limited | 17 |
5 |
Washington University | 1473 |
5 |
GTO Pharma, LLC. | 5 |
5 |
Agile Therapeutics, Inc. | 45 |
4 |
Icosagen Cell Factory OU | 17 |
4 |
ITF Research Pharma, S.L.U. | 16 |
4 |
Replicor Inc. | 33 |
4 |
Lupin Inc. | 85 |
4 |
JangoBio, LLC | 6 |
4 |
The Board of Trustees of the University of Illinois | 2623 |
3 |
American Infertility of New York | 13 |
3 |
Endorecherche, Inc. | 27 |
3 |
Forendo Pharma Ltd. | 19 |
3 |
Shanghai Jiao Tong University | 1020 |
3 |
Shimoda Biotech (Pty) Ltd. | 6 |
3 |
Universite Laval | 703 |
3 |
University of Pittsburgh - Of the Commonwealth System of Higher Education | 2912 |
3 |
Other owners | 197 |